Neuspera Medical Announces Initial Close of $26M Series B Equity FinancingGlobal Healthcare Investor 6 Dimensions Capital Leads Round SAN JOSE, Calif., January 24, 2018-- Neuspera Medical Inc., a clinical stage, private venture capital backed neuromodulation company, today announced the initial closing of their Series B equity financing. The $26 million financing was led by 6 Dimensions Capital with all existing investors from Series A also participating including Action Potential Venture Capital and Windham Venture Partners. Ching Zhu, Ph.D., a Managing Partner at 6 Dimensions Capital, joined the Board of Directors.